* Chugai will continue to be responsible for product
manufacturing and supply of Nemolizumab.
The post BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Chugai will continue to be responsible for product
manufacturing and supply of Nemolizumab.
The post BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab appeared first on NASDAQ.